Strategic Initiative

Slingshot members are tracking this corporate initiative:

Bristol-Myers Squibb (BMY) Reaches Exclusive Worldwide Agreement with PsiOxus Therapeutics to Develop an "Armed" Oncolytic Virus NG-348 to Treat Solid Tumors

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
BMY Community voting in process
PsiOxus Therapeutics Community voting in process
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Dec 20, 2016
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2019
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Exclusive Worldwide Agreement, Ng-348, Armed Oncolytic Virus, Sold Tumors